Total Payments
$758.69
2024 Payments
$51.98
Companies
4
Transactions
33
Medicare Patients
655
Medicare Billing
$128,828
Payment Breakdown by Category
Food & Beverage$694.15 (91.5%)
Education$64.54 (8.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $694.15 | 31 | 91.5% |
| Education | $64.54 | 2 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $402.05 | 20 | $0 (2023) |
| Allergan Inc. | $170.01 | 2 | $0 (2018) |
| ABBVIE INC. | $94.48 | 6 | $0 (2024) |
| IBSA Pharma Inc. | $92.15 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.98 | 3 | IBSA Pharma Inc. ($36.79) |
| 2023 | $43.22 | 2 | Novo Nordisk Inc ($43.22) |
| 2022 | $62.14 | 3 | ABBVIE INC. ($38.33) |
| 2021 | $28.66 | 2 | AbbVie Inc. ($28.66) |
| 2019 | $43.63 | 3 | Novo Nordisk Inc ($31.72) |
| 2018 | $293.51 | 10 | Allergan Inc. ($170.01) |
| 2017 | $235.55 | 10 | Novo Nordisk Inc ($223.25) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Endocrinology | ||||||
| 05/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Endocrinology | ||||||
| 01/24/2024 | ABBVIE INC. | SYNTHROID (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Obesity | ||||||
| 02/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Obesity | ||||||
| 10/04/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $23.81 | General |
| Category: Endocrinology | ||||||
| 09/16/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2019 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $11.91 | General |
| Category: Endocrinology | ||||||
| 10/03/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Obesity | ||||||
| 02/27/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Obesity | ||||||
| 12/19/2018 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Endocrinology | ||||||
| 10/09/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Obesity | ||||||
| 08/14/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Obesity | ||||||
| 07/19/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $68.33 | General |
| 07/18/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $101.68 | General |
| 06/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Obesity | ||||||
| 05/31/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Obesity | ||||||
| 04/19/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Obesity | ||||||
| 03/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Obesity | ||||||
| 01/23/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Obesity | ||||||
| 10/26/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: Obesity | ||||||
| 09/19/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 119 | 437 | $57,988 | $36,176 |
| 2022 | 4 | 162 | 441 | $55,380 | $35,640 |
| 2021 | 4 | 190 | 410 | $48,148 | $32,332 |
| 2020 | 4 | 184 | 440 | $45,084 | $24,680 |
Total Patients
655
Total Services
1,728
Medicare Billing
$128,828
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 386 | $53,073 | $32,301 | 60.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $4,215 | $3,696 | 87.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 20 | $700.00 | $178.84 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 301 | $41,388 | $25,849 | 62.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 84 | $8,232 | $4,940 | 60.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $5,130 | $4,690 | 91.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 18 | $630.00 | $161.18 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 214 | $28,908 | $19,328 | 66.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 140 | $13,300 | $7,705 | 57.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $5,415 | $5,138 | 94.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 15 | $525.00 | $161.94 | 30.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 292 | $27,675 | $13,964 | 50.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 93 | $12,484 | $6,299 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 40 | 40 | $4,400 | $4,290 | 97.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 15 | $525.00 | $126.82 | 24.2% |
About Dr. Marla Wohlman, M.D
Dr. Marla Wohlman, M.D is a Family Medicine healthcare provider based in Millbrook, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225178031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marla Wohlman, M.D has received a total of $758.69 in payments from pharmaceutical and medical device companies, with $51.98 received in 2024. These payments were reported across 33 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($694.15).
As a Medicare-enrolled provider, Wohlman has provided services to 655 Medicare beneficiaries, totaling 1,728 services with total Medicare billing of $128,828. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Millbrook, AL
- Active Since 02/08/2007
- Last Updated 04/19/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225178031
Products in Payments
- Saxenda (Drug) $358.83
- Tirosint (Drug) $92.15
- SYNTHROID (Drug) $82.18
- Wegovy (Drug) $43.22
- Androgel (Drug) $12.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Millbrook
Mr. Steven Allen, Md, MD
Family Medicine — Payments: $1,471
Family Medicine $1,471
Margaret Coughlan, M.d, M.D
Family Medicine — Payments: $368.81
Family Medicine $368.81
Daren Garb, M.d, M.D
Family Medicine — Payments: $58.55
Family Medicine $58.55
Christie Garb, Md, MD
Family Medicine
Family Medicine
Dr. John Supple, M.d, M.D
Family Medicine
Family Medicine